Concepts (167)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
Name | Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
---|
Emigrants and Immigrants | 6 | 2019 | 550 | 1.860 |
Why?
|
Group Homes | 6 | 2024 | 59 | 1.630 |
Why?
|
HIV Infections | 18 | 2024 | 17532 | 1.240 |
Why?
|
Patient Acceptance of Health Care | 4 | 2019 | 3230 | 0.880 |
Why?
|
Developmental Disabilities | 2 | 2024 | 1519 | 0.600 |
Why?
|
Cultural Competency | 1 | 2019 | 303 | 0.510 |
Why?
|
Drug Resistance, Viral | 3 | 2024 | 868 | 0.510 |
Why?
|
Anti-HIV Agents | 7 | 2024 | 4561 | 0.500 |
Why?
|
Urban Health Services | 1 | 2016 | 176 | 0.490 |
Why?
|
Community Health Centers | 1 | 2019 | 469 | 0.490 |
Why?
|
Patient Dropouts | 1 | 2017 | 411 | 0.490 |
Why?
|
Mass Screening | 3 | 2019 | 5454 | 0.470 |
Why?
|
Transients and Migrants | 1 | 2017 | 170 | 0.470 |
Why?
|
Social Stigma | 2 | 2018 | 788 | 0.450 |
Why?
|
Interprofessional Relations | 1 | 2019 | 998 | 0.420 |
Why?
|
Sexually Transmitted Diseases | 1 | 2019 | 668 | 0.420 |
Why?
|
Genital Diseases, Female | 2 | 2010 | 192 | 0.400 |
Why?
|
Office Visits | 1 | 2016 | 593 | 0.390 |
Why?
|
Research Personnel | 1 | 2016 | 589 | 0.380 |
Why?
|
Endometrium | 2 | 2010 | 406 | 0.360 |
Why?
|
Protease Inhibitors | 1 | 2012 | 750 | 0.300 |
Why?
|
AIDS Serodiagnosis | 1 | 2009 | 220 | 0.300 |
Why?
|
Mental Disorders | 4 | 2024 | 6869 | 0.280 |
Why?
|
Medical Informatics | 1 | 2014 | 744 | 0.280 |
Why?
|
Substance-Related Disorders | 2 | 2019 | 4421 | 0.250 |
Why?
|
Infertility, Female | 2 | 2010 | 763 | 0.240 |
Why?
|
Saliva | 1 | 2009 | 852 | 0.230 |
Why?
|
South Africa | 5 | 2013 | 1873 | 0.230 |
Why?
|
Hospitalization | 1 | 2024 | 10816 | 0.230 |
Why?
|
Quarantine | 2 | 2023 | 186 | 0.220 |
Why?
|
Acquired Immunodeficiency Syndrome | 1 | 2012 | 2204 | 0.220 |
Why?
|
Antiretroviral Therapy, Highly Active | 1 | 2012 | 1900 | 0.220 |
Why?
|
Puerto Rico | 3 | 2018 | 380 | 0.210 |
Why?
|
Ukraine | 1 | 2023 | 151 | 0.210 |
Why?
|
Colonialism | 1 | 2003 | 35 | 0.200 |
Why?
|
Mycobacterium tuberculosis | 2 | 2010 | 1911 | 0.200 |
Why?
|
Leprosy | 1 | 2003 | 125 | 0.200 |
Why?
|
Prenatal Care | 1 | 2009 | 1158 | 0.190 |
Why?
|
Physicians | 1 | 2019 | 4591 | 0.180 |
Why?
|
Stereotyping | 1 | 2003 | 241 | 0.180 |
Why?
|
Biomedical Research | 1 | 2016 | 3459 | 0.180 |
Why?
|
Tuberculosis | 2 | 2010 | 2011 | 0.180 |
Why?
|
Adult | 19 | 2024 | 223305 | 0.180 |
Why?
|
Canada | 2 | 2023 | 2126 | 0.170 |
Why?
|
Primary Health Care | 1 | 2016 | 4735 | 0.170 |
Why?
|
Massachusetts | 4 | 2024 | 8890 | 0.160 |
Why?
|
Lost to Follow-Up | 1 | 2019 | 124 | 0.150 |
Why?
|
HIV-1 | 2 | 2013 | 6948 | 0.150 |
Why?
|
Public Health | 2 | 2019 | 2680 | 0.150 |
Why?
|
Treatment Failure | 3 | 2013 | 2659 | 0.150 |
Why?
|
Spain | 1 | 2019 | 483 | 0.140 |
Why?
|
CD4 Lymphocyte Count | 2 | 2016 | 2586 | 0.140 |
Why?
|
Pregnancy Complications, Infectious | 1 | 2009 | 2183 | 0.140 |
Why?
|
Qualitative Research | 2 | 2019 | 3138 | 0.140 |
Why?
|
Serologic Tests | 1 | 2019 | 382 | 0.140 |
Why?
|
United States | 9 | 2023 | 72945 | 0.140 |
Why?
|
Electronic Health Records | 1 | 2014 | 4880 | 0.130 |
Why?
|
Europe | 1 | 2023 | 3430 | 0.130 |
Why?
|
Humans | 29 | 2024 | 766812 | 0.130 |
Why?
|
Caribbean Region | 1 | 2016 | 193 | 0.130 |
Why?
|
Acculturation | 1 | 2017 | 179 | 0.130 |
Why?
|
Affective Symptoms | 1 | 2018 | 418 | 0.130 |
Why?
|
Adolescent | 8 | 2024 | 88902 | 0.120 |
Why?
|
Disabled Persons | 1 | 2024 | 1209 | 0.120 |
Why?
|
Sexual Partners | 1 | 2019 | 804 | 0.110 |
Why?
|
Communication Barriers | 1 | 2017 | 418 | 0.110 |
Why?
|
Endometritis | 2 | 2010 | 49 | 0.110 |
Why?
|
Algorithms | 1 | 2014 | 14073 | 0.110 |
Why?
|
Resilience, Psychological | 1 | 2021 | 807 | 0.110 |
Why?
|
Focus Groups | 1 | 2019 | 1459 | 0.100 |
Why?
|
Perception | 1 | 2019 | 1204 | 0.100 |
Why?
|
Male | 17 | 2024 | 364154 | 0.100 |
Why?
|
Female | 17 | 2024 | 396532 | 0.090 |
Why?
|
Patient Preference | 1 | 2019 | 946 | 0.090 |
Why?
|
Granuloma | 2 | 2010 | 329 | 0.090 |
Why?
|
Proportional Hazards Models | 2 | 2024 | 12536 | 0.090 |
Why?
|
Anti-Bacterial Agents | 1 | 2009 | 7475 | 0.090 |
Why?
|
Mentors | 1 | 2016 | 671 | 0.090 |
Why?
|
Continuity of Patient Care | 1 | 2018 | 1077 | 0.090 |
Why?
|
Reference Standards | 1 | 2014 | 1010 | 0.090 |
Why?
|
Infertility, Male | 2 | 2010 | 396 | 0.090 |
Why?
|
Viral Load | 3 | 2018 | 3385 | 0.090 |
Why?
|
Interviews as Topic | 1 | 2017 | 2741 | 0.080 |
Why?
|
Counseling | 1 | 2017 | 1550 | 0.080 |
Why?
|
Data Mining | 1 | 2014 | 560 | 0.080 |
Why?
|
Minority Groups | 1 | 2016 | 1208 | 0.080 |
Why?
|
Registries | 2 | 2016 | 8352 | 0.080 |
Why?
|
Herbaspirillum | 1 | 2008 | 8 | 0.080 |
Why?
|
Reagent Kits, Diagnostic | 1 | 2009 | 238 | 0.070 |
Why?
|
Residence Characteristics | 1 | 2018 | 2116 | 0.070 |
Why?
|
Poverty Areas | 1 | 2009 | 268 | 0.070 |
Why?
|
Middle Aged | 7 | 2024 | 223267 | 0.070 |
Why?
|
Social Support | 1 | 2017 | 2191 | 0.070 |
Why?
|
Clinical Laboratory Techniques | 1 | 2012 | 746 | 0.070 |
Why?
|
Microbial Sensitivity Tests | 2 | 2013 | 1972 | 0.070 |
Why?
|
False Positive Reactions | 1 | 2009 | 958 | 0.070 |
Why?
|
Health Resources | 1 | 2012 | 950 | 0.070 |
Why?
|
Gram-Negative Bacterial Infections | 1 | 2008 | 239 | 0.060 |
Why?
|
Child | 3 | 2024 | 80670 | 0.060 |
Why?
|
Boston | 1 | 2019 | 9346 | 0.060 |
Why?
|
Fertilization in Vitro | 2 | 2010 | 1301 | 0.060 |
Why?
|
Randomized Controlled Trials as Topic | 1 | 2022 | 10384 | 0.060 |
Why?
|
Area Under Curve | 1 | 2009 | 1639 | 0.060 |
Why?
|
HIV | 1 | 2012 | 1588 | 0.060 |
Why?
|
Antitubercular Agents | 2 | 2010 | 1380 | 0.060 |
Why?
|
Reverse Transcriptase Polymerase Chain Reaction | 1 | 2012 | 4570 | 0.060 |
Why?
|
Language | 1 | 2014 | 1550 | 0.060 |
Why?
|
Mental Health | 1 | 2019 | 3269 | 0.060 |
Why?
|
Health Knowledge, Attitudes, Practice | 1 | 2019 | 4056 | 0.060 |
Why?
|
Physician-Patient Relations | 1 | 2017 | 3266 | 0.060 |
Why?
|
Sequence Analysis, RNA | 1 | 2012 | 2039 | 0.060 |
Why?
|
Genotype | 3 | 2013 | 13036 | 0.060 |
Why?
|
Young Adult | 3 | 2024 | 59939 | 0.050 |
Why?
|
Anti-Retroviral Agents | 1 | 2013 | 1787 | 0.050 |
Why?
|
Pandemics | 4 | 2023 | 8734 | 0.050 |
Why?
|
Cost-Benefit Analysis | 2 | 2012 | 5536 | 0.050 |
Why?
|
Clinical Trials as Topic | 2 | 2023 | 8045 | 0.050 |
Why?
|
Healthcare Disparities | 1 | 2018 | 3411 | 0.050 |
Why?
|
Biopsy | 2 | 2010 | 6779 | 0.050 |
Why?
|
Flow Cytometry | 1 | 2012 | 5890 | 0.050 |
Why?
|
Health Services Accessibility | 1 | 2018 | 5513 | 0.040 |
Why?
|
Models, Theoretical | 1 | 2012 | 3563 | 0.040 |
Why?
|
History, 19th Century | 1 | 2003 | 714 | 0.040 |
Why?
|
Cross-Sectional Studies | 3 | 2023 | 26309 | 0.040 |
Why?
|
Risk Factors | 2 | 2024 | 74889 | 0.040 |
Why?
|
Aged | 2 | 2024 | 171344 | 0.040 |
Why?
|
Cystic Fibrosis | 1 | 2008 | 1285 | 0.040 |
Why?
|
Depression | 1 | 2018 | 8225 | 0.040 |
Why?
|
Cuba | 1 | 2018 | 48 | 0.040 |
Why?
|
Florida | 1 | 2018 | 417 | 0.030 |
Why?
|
Delivery of Health Care | 1 | 2014 | 5367 | 0.030 |
Why?
|
Case Management | 1 | 2018 | 276 | 0.030 |
Why?
|
Infection Control | 1 | 2023 | 984 | 0.030 |
Why?
|
Nursing Homes | 1 | 2023 | 1084 | 0.030 |
Why?
|
South America | 1 | 2016 | 180 | 0.030 |
Why?
|
History, 20th Century | 1 | 2003 | 2764 | 0.030 |
Why?
|
Sensitivity and Specificity | 1 | 2009 | 14653 | 0.030 |
Why?
|
North America | 1 | 2016 | 1287 | 0.020 |
Why?
|
Ritonavir | 1 | 2013 | 331 | 0.020 |
Why?
|
Caregivers | 1 | 2023 | 2303 | 0.020 |
Why?
|
Treatment Outcome | 3 | 2016 | 65286 | 0.020 |
Why?
|
Fallopian Tubes | 1 | 2010 | 179 | 0.020 |
Why?
|
Retrospective Studies | 3 | 2018 | 81657 | 0.020 |
Why?
|
Genes, rRNA | 1 | 2008 | 73 | 0.020 |
Why?
|
Burkholderia cepacia complex | 1 | 2008 | 24 | 0.020 |
Why?
|
Patient Compliance | 1 | 2018 | 2694 | 0.020 |
Why?
|
Health Personnel | 1 | 2021 | 3384 | 0.020 |
Why?
|
Pregnancy | 1 | 2009 | 30236 | 0.020 |
Why?
|
DNA, Ribosomal | 1 | 2008 | 300 | 0.020 |
Why?
|
Sequence Homology, Nucleic Acid | 1 | 2008 | 1057 | 0.020 |
Why?
|
Longitudinal Studies | 1 | 2023 | 14762 | 0.020 |
Why?
|
RNA, Bacterial | 1 | 2008 | 393 | 0.020 |
Why?
|
Life Expectancy | 1 | 2012 | 1248 | 0.020 |
Why?
|
RNA, Viral | 1 | 2013 | 2867 | 0.010 |
Why?
|
RNA, Ribosomal, 16S | 1 | 2008 | 1044 | 0.010 |
Why?
|
Comorbidity | 1 | 2018 | 10580 | 0.010 |
Why?
|
Cohort Studies | 2 | 2018 | 41706 | 0.010 |
Why?
|
DNA, Bacterial | 1 | 2008 | 1477 | 0.010 |
Why?
|
Cognition | 1 | 2018 | 7057 | 0.010 |
Why?
|
Prevalence | 1 | 2018 | 15835 | 0.010 |
Why?
|
Phylogeny | 1 | 2008 | 2840 | 0.010 |
Why?
|
Animals | 1 | 2009 | 168939 | 0.010 |
Why?
|
Sequence Analysis, DNA | 1 | 2008 | 4780 | 0.010 |
Why?
|
Models, Biological | 1 | 2012 | 9464 | 0.010 |
Why?
|
Molecular Sequence Data | 1 | 2008 | 17609 | 0.010 |
Why?
|
Infant | 1 | 2013 | 36459 | 0.010 |
Why?
|
Child, Preschool | 1 | 2013 | 42577 | 0.010 |
Why?
|
Concepts
(167)
Derived automatically from this person's publications.
Explore
_
Co-Authors
(31)
People in Profiles who have published with this person.
Explore
_
Similar People
(60)
People who share similar concepts with this person.
Explore
_
Same Department
People in same department with this person.
Explore
_
Physical Neighbors
People whose addresses are nearby this person.
_